First cases of SARS-CoV-2 BA.2.86 in Denmark, 2023
Morten Rasmussen, Pikka Jokelainen(Statens Serum Institut), Morten Hoppe(Gentofte Hospital), Lasse Dam Rasmussen(Statens Serum Institut), Henrik Ullum(Statens Serum Institut), Ria Lassaunière(Statens Serum Institut), Marc Stegger(Statens Serum Institut), Marianne Nielsine Skov(University of Southern Denmark), Sharmin Baig(Statens Serum Institut), Lasse Engbo Christiansen, Rune M. Pedersen(University of Southern Denmark), Lene Nielsen(University of Southern Denmark), Arieh S. Cohen(Statens Serum Institut), Kirsten Ellegaard(Statens Serum Institut), Vithiagaran Gunalan(Statens Serum Institut), Lasse S Vestergaard(Statens Serum Institut), Marc Bennedbæk(Statens Serum Institut), Tyra Grove Krause(Statens Serum Institut), Silje Vermedal Hoegh(University of Southern Denmark), Nicolai Balle Larsen(Statens Serum Institut), Tine Graakjær Larsen, Kristina Træholt Franck, Frederik Trier Møller(Statens Serum Institut), Thomas Vognbjerg Sydenham(University of Southern Denmark), Charlotta Polacek(Statens Serum Institut), Kat Steinke(German Center for Infection Research), Thomas Emil Andersen(University of Copenhagen), Katja Spieß(University of Copenhagen), Anders Fomsgaard(Statens Serum Institut), Man‐Hung Eric Tang(Copenhagen University Hospital), Amanda Gammelby Qvesel(Statens Serum Institut), Raphael N. Sieber(Statens Serum Institut)
Cited by 67
Related Papers
antiSMASH 5.0: updates to the secondary metabolite genome mining pipeline
|Nucleic Acids Research|2019|3.1k
Multiple sclerosis genomic map implicates peripheral immune cells and microglia in susceptibility
|Science|2019|1.4k
Rapid detection, differentiation and typing of methicillin-resistant Staphylococcus aureus harbouring either mecA or the new mecA homologue mecALGA251
|Clinical Microbiology and Infection|2011|429